Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice

Tsuyoshi Itoh, Esteban Celis

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Much attention has been focused on transcutaneous immunization strategies to stimulate systemic cytotoxic T lymphocyte responses leading to anti-tumor or anti-microbial immunity. Here we report that topical application of vaccines consisting of synthetic peptides formulated with imiquimod, a Toll-like receptor agonist that functions as a potent adjuvant generates strong T cell responses that exhibit effective anti-tumor effects in a murine melanoma model system. These results support the use of peptide-based transcutaneous vaccines as a noninvasive and effective strategy for anti-tumor immunotherapy.

Original languageEnglish (US)
Pages (from-to)430-437
Number of pages8
JournalJournal of Immunotherapy
Volume28
Issue number5
DOIs
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

T-Lymphocyte Epitopes
Immunity
Immunization
imiquimod
Peptides
Neoplasms
Synthetic Vaccines
Toll-Like Receptors
Cytotoxic T-Lymphocytes
Immunotherapy
Melanoma
Vaccines
T-Lymphocytes

Keywords

  • Animal model
  • Cutaneous vaccine
  • Melanoma
  • Toll-like receptor adjuvant

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology
  • Cancer Research

Cite this

Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice. / Itoh, Tsuyoshi; Celis, Esteban.

In: Journal of Immunotherapy, Vol. 28, No. 5, 01.01.2005, p. 430-437.

Research output: Contribution to journalArticle

@article{e49b336df8954a0eb1686cc9abd82583,
title = "Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice",
abstract = "Much attention has been focused on transcutaneous immunization strategies to stimulate systemic cytotoxic T lymphocyte responses leading to anti-tumor or anti-microbial immunity. Here we report that topical application of vaccines consisting of synthetic peptides formulated with imiquimod, a Toll-like receptor agonist that functions as a potent adjuvant generates strong T cell responses that exhibit effective anti-tumor effects in a murine melanoma model system. These results support the use of peptide-based transcutaneous vaccines as a noninvasive and effective strategy for anti-tumor immunotherapy.",
keywords = "Animal model, Cutaneous vaccine, Melanoma, Toll-like receptor adjuvant",
author = "Tsuyoshi Itoh and Esteban Celis",
year = "2005",
month = "1",
day = "1",
doi = "10.1097/01.cji.0000171289.78495.b0",
language = "English (US)",
volume = "28",
pages = "430--437",
journal = "Journal of Immunotherapy",
issn = "1053-8550",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice

AU - Itoh, Tsuyoshi

AU - Celis, Esteban

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Much attention has been focused on transcutaneous immunization strategies to stimulate systemic cytotoxic T lymphocyte responses leading to anti-tumor or anti-microbial immunity. Here we report that topical application of vaccines consisting of synthetic peptides formulated with imiquimod, a Toll-like receptor agonist that functions as a potent adjuvant generates strong T cell responses that exhibit effective anti-tumor effects in a murine melanoma model system. These results support the use of peptide-based transcutaneous vaccines as a noninvasive and effective strategy for anti-tumor immunotherapy.

AB - Much attention has been focused on transcutaneous immunization strategies to stimulate systemic cytotoxic T lymphocyte responses leading to anti-tumor or anti-microbial immunity. Here we report that topical application of vaccines consisting of synthetic peptides formulated with imiquimod, a Toll-like receptor agonist that functions as a potent adjuvant generates strong T cell responses that exhibit effective anti-tumor effects in a murine melanoma model system. These results support the use of peptide-based transcutaneous vaccines as a noninvasive and effective strategy for anti-tumor immunotherapy.

KW - Animal model

KW - Cutaneous vaccine

KW - Melanoma

KW - Toll-like receptor adjuvant

UR - http://www.scopus.com/inward/record.url?scp=24144494203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144494203&partnerID=8YFLogxK

U2 - 10.1097/01.cji.0000171289.78495.b0

DO - 10.1097/01.cji.0000171289.78495.b0

M3 - Article

C2 - 16113599

AN - SCOPUS:24144494203

VL - 28

SP - 430

EP - 437

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1053-8550

IS - 5

ER -